First Time Loading...
S

Shin Nippon Biomedical Laboratories Ltd
TSE:2395

Watchlist Manager
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Watchlist
Price: 1 542 JPY Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shin Nippon Biomedical Laboratories Ltd

Wall Street analysts forecast Shin Nippon Biomedical Laboratories Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shin Nippon Biomedical Laboratories Ltd is 2 856 JPY with a low forecast of 2 828 JPY and a high forecast of 2 940 JPY.

Lowest Forecast
Wall Street Target
2 828 JPY
83% Upside
Average Forecast
Wall Street Target
2 856 JPY
85% Upside
Highest Forecast
Wall Street Target
2 940 JPY
91% Upside
Lowest
Price Target
2 828 JPY
83% Upside
Average
Price Target
2 856 JPY
85% Upside
Highest
Price Target
2 940 JPY
91% Upside
Shin Nippon Biomedical Laboratories Ltd Competitors:
Price Targets
M
300463
Maccura Biotechnology Co Ltd
44% Upside
BROOKS
Brooks Laboratories Ltd
49% Downside
M
688114
MGI Tech Co Ltd
69% Upside
AZTA
Azenta Inc
35% Upside
M
300463
Maccura Biotechnology Co Ltd
44% Upside
BROOKS
Brooks Laboratories Ltd
49% Downside
M
688114
MGI Tech Co Ltd
69% Upside
AZTA
Azenta Inc
35% Upside
DHR
Danaher Corp
10% Upside
LONN
Lonza Group AG
8% Upside
STVN
Stevanato Group SpA
25% Upside
M
MLC
Malin Corporation PLC
111% Upside

Revenue
Forecast

Revenue Estimate
Shin Nippon Biomedical Laboratories Ltd

For the last 8 years the compound annual growth rate for Shin Nippon Biomedical Laboratories Ltd's revenue is 4%. The projected CAGR for the next 3 years is 14%.

4%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shin Nippon Biomedical Laboratories Ltd

The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's operating income for the next 1 year is 131 878%.

N/A
Past Growth
131 878%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shin Nippon Biomedical Laboratories Ltd

The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's net income for the next 3 years is 8%.

N/A
Past Growth
8%
Estimated Growth
Estimates Accuracy
20%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shin Nippon Biomedical Laboratories Ltd's stock price target?
Price Target
2 856 JPY

According to Wall Street analysts, the average 1-year price target for Shin Nippon Biomedical Laboratories Ltd is 2 856 JPY with a low forecast of 2 828 JPY and a high forecast of 2 940 JPY.

What is Shin Nippon Biomedical Laboratories Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Shin Nippon Biomedical Laboratories Ltd's revenue is 4%. The projected CAGR for the next 3 years is 14%.

What is Shin Nippon Biomedical Laboratories Ltd's Operating Income forecast?
Projected CAGR
131 878%

The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's operating income for the next 1 year is 131 878%.

What is Shin Nippon Biomedical Laboratories Ltd's Net Income forecast?
Projected CAGR
8%

The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's net income for the next 3 years is 8%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.